Zafgen, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Boston MA United States (2005)
Status: Acquired by Larimar Therapeutics (2020)

Organization Overview

First Clinical Trial
2009
NCT01028261
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Mergers & Acquisitions

Historical Acquisition Tree